Esther Rajavelu Spero Therapeutics, Inc. (SPRO) insider trading activity
Esther Rajavelu is CFO & CBO of Spero Therapeutics, Inc.. Currently has a direct ownership of 724,720 shares of SPRO, which is worth approximately $601,517. The most recent transaction as insider was on Feb 05, 2025, when has been sold 20,689 shares (Common Stock) at a price of $0.78 per share, resulting in proceeds of $16,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
725K
91.08%
3M change
72.61%
12M change
Total Value Held
$601,517
Esther Rajavelu Transaction History
Also insider at
ER
Esther Rajavelu
CFO & CBO
Cambridge, MA